An interventional study of remote reiki in Organ or Tissue Transplant; Complications and Reiki, sponsored by Bozok University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-06.
Sponsored by Bozok University · Not applicable, Interventional, and Supportive care
The treatment and care of chronic kidney failure is a long-term process, and patients are significantly affected by this condition. The fact that patients spend much of their daily lives attending hemodialysis sessions two or three times a week considerably limits their life activities. dition to medical treatment, a non-pharmacological Therefore, individuals may become partially or completely dependent. Coping with various symptoms brought on by this chronic disease, adapting to the restrictions required by treatment, preventing complications, and improving quality of life also bring about physical, cognitive, and psychological challenges. Patients are aware that they can only regain their previous health through organ transplantation; however, since it is uncertain when a suitable donor will be found, they may experience intense feelings of hopelessness. The chronic illness itself and the hemodialysis sessions frequently lead to symptoms such as pain and fatigue. In admethod such as distant Reiki may be supportive in coping with symptoms like hopelessness, fatigue, and pain. Numerous evidence-based studies in the literature have demonstrated that distant Reiki practices support symptom management in many chronic diseases through their effects on the parasympathetic nervous system. However, the effects of distant Reiki on hopelessness, fatigue, and pain in individuals awaiting organ donation have not yet been investigated.
Therefore, this study is planned to be conducted as a randomized controlled trial with two groups. Fifty patients awaiting organ donation who meet the inclusion criteria will be included in the study. Data will be collected using the "Personal Information Form," "Beck Hopelessness Scale," "Fatigue Severity Scale," and "Brief Pain Inventory." Analyses will be performed using an appropriate statistical software package. We believe that distant Reiki practices may have positive effects on hopelessness, fatigue, and pain among hemodialysis patients awaiting organ donation. It is known that the majority of nurses worldwide hold Reiki practice certifications and use this method in chronic diseases. The main aim of this study is to support symptom management and strengthen coping mechanisms in individuals through distant Reiki practices.
2,219 studies on the registry are indexed under Pain; 917 are open to participants now.
This study's enrollment of 30 is below the median of 70 across 1,904 interventional studies indexed under Pain.
Browse Pain studies →Bozok University is the lead sponsor of 53 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
remote reiki
Behavioral: remote reiki
control
Patients in the intervention group will be contacted by telephone. They will be provided with a suitable environment. A certified assistant researcher will initiate the remote Reiki application. Each application is expected to last an average of 35-40 minutes. The first remote Reiki session will be conducted on the evening of the patient's haemodialysis day. The sessions will take place three times a week for a total of four weeks. After the application is completed, vital signs will be taken again from the intervention group patients, and the Beck Hopelessness Scale, Fatigue Severity Scale, and Brief Pain Inventory will be completed. The data collection tool will be completed a second time the day after the last application and a third time one month later. The effects of Reiki therapy on hopelessness, fatigue, and pain will be evaluated using the Personal Information Form, Beck Hopelessness Scale, Fatigue Severity Scale, and Brief Pain Inventory.
Hopelessness Level
Hopelessness level will be assessed using the Beck Hopelessness Scale (BHS). The scale consists of 20 items and measures negative expectations about the future. Higher total scores indicate greater levels of hopelessness. Total scale score (0-20) Unit of Measure: Scale total score (0-20)
Time frame: From enrollment to the end of treatment at 8 weeks
Pain Intensity and Pain Interference
Pain intensity and pain-related interference with daily activities will be assessed using the numeric raito scale (NRS). The instrument evaluates pain severity and its impact on functioning. Pain severity score and pain interference score Unit of Measure: Scale total score (0-10)
Time frame: From enrollment to the end of treatment at 8 weeks
Fatigue Severity
Fatigue severity will be measured using the Fatigue Severity Scale (FSS), a 9-item self-report questionnaire evaluating the impact of fatigue on daily functioning. Higher scores indicate greater fatigue severity. Unit of Measure: Total scale score (1-7)
Time frame: Baseline (first dialysis day), at 4 weeks (end of intervention), and 1 month after the final intervention session
Systolic Blood Pressure
Description: Systolic blood pressure measured under standardized resting conditions using an automated monitor. Unit of Measure: mmHg
Time frame: Baseline to 8 weeks
Diastolic Blood Pressure
Description: Diastolic blood pressure measured under standardized resting conditions using an automated monitor. Unit of Measure: mmHg
Time frame: Baseline to 8 weeks
Heart Rate
Description: Resting heart rate measured using an automated vital signs monitor. Unit of Measure: beats per minute (bpm)
Time frame: Baseline to 8 weeks
Body Temperature
Description: Body temperature measured using a digital thermometer under standardized conditions. Unit of Measure: °C
Time frame: Baseline to 8 weeks
Plan to share: Yes — De-identified individual participant data (IPD) underlying the results reported in publications (including outcome measure data, demographic variables, and relevant clinical variables) will be made available upon reasonable request to the corresponding author. All shared data will be fully anonymized to protect participant confidentiality and will exclude any personally identifiable information.
Supporting information: Sap, Csr
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bozok University